Efecto de la densidad muscular en pacientes con cáncer de próstata metastásico tratados con terapia de privación androgénica

Perachino, 2010, Testosterone levels in patients with metastatic prostate cancer treated with luteinizing hormone-releasing hormone therapy: prognostic significance?, BJU Int, 105, 648, 10.1111/j.1464-410X.2009.08814.x Gravis, 2015, Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model, Eur Urol, 68, 196, 10.1016/j.eururo.2014.09.022 Cruz-Jentoft, 2010, Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People, Age Ageing, 39, 412, 10.1093/ageing/afq034 Cruz-Jentoft, 2019, Sarcopenia: revised European consensus on definition and diagnosis, Age Ageing, 48, 16, 10.1093/ageing/afy169 Kim, 2013, Sarcopenia: definition, epidemiology, and pathophysiology, J Bone Metab, 20, 1, 10.11005/jbm.2013.20.1.1 Shachar, 2016, Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review, Eur J Cancer, 57, 58, 10.1016/j.ejca.2015.12.030 Joglekar, 2015, Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma, J Surg Oncol, 111, 771, 10.1002/jso.23862 Wagner, 2016, Clinical and morphometric parameters of frailty for prediction of mortality following hepatopancreaticobiliary surgery in the elderly, Br J Surg, 103, e83, 10.1002/bjs.10037 Tankel, 2020, Sarcopenia defined by muscle quality rather than quantity predicts complications following laparoscopic right hemicolectomy, Int J Colorectal Dis, 35, 85, 10.1007/s00384-019-03423-x Sweeney, 2015, Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer, N Engl J Med, 373, 737, 10.1056/NEJMoa1503747 Fizazi, 2017, Abiraterone plus Prednisone in Metastatic Castration-Sensitive Prostate Cancer, N Engl J Med, 377, 352, 10.1056/NEJMoa1704174 Chi, 2019, Apalutamide for Metastatic Castration-Sensitive Prostate Cancer, N Engl J Med, 381, 13, 10.1056/NEJMoa1903307 Armstrong, 2019, ARCHES: A Randomized Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer, J Clin Oncol Davis, 2019, Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer, N Engl J Med, 381, 121, 10.1056/NEJMoa1903835 Soloway, 1988, Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan, Cancer, 61, 195, 10.1002/1097-0142(19880101)61:1<195::AID-CNCR2820610133>3.0.CO;2-Y Glass, 2003, Metastatic carcinoma of the prostate: identifying prognostic groups using recursive partitioning, J Urol, 169, 164, 10.1016/S0022-5347(05)64059-1 Gravis, 2013, Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial, Lancet Oncol, 14, 149, 10.1016/S1470-2045(12)70560-0 Harada, 2016, Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma, Dis Esophagus Off J Int Soc Dis Esophagus, 29, 627, 10.1111/dote.12381 Prado, 2008, Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study, Lancet Oncol, 9, 629, 10.1016/S1470-2045(08)70153-0 Harimoto, 2013, Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma, Br J Surg, 100, 1523, 10.1002/bjs.9258 Fukushima, 2016, Prognostic Significance of Sarcopenia in Patients with Metastatic Renal Cell Carcinoma, J Urol, 195, 26, 10.1016/j.juro.2015.08.071 Smith, 2014, Sarcopenia as a predictor of complications and survival following radical cystectomy, J Urol, 191, 1714, 10.1016/j.juro.2013.12.047 Fukushima, 2016, Prognostic significance of sarcopenia in upper tract urothelial carcinoma patients treated with radical nephroureterectomy, Cancer Med, 5, 2213, 10.1002/cam4.795 Versteeg, 2018, Higher Muscle Strength Is Associated with Prolonged Survival in Older Patients with Advanced Cancer, Oncologist, 23, 580, 10.1634/theoncologist.2017-0193 Stangl-Kremser, 2019, Assessment of body composition in the advanced stage of castration-resistant prostate cancer: special focus on sarcopenia, Prostate Cancer Prostatic Dis, 309 Shen, 2004, Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image, J Appl Physiol, 97, 2333, 10.1152/japplphysiol.00744.2004 Hamaguchi, 2016, Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults, Nutrition, 32, 1200, 10.1016/j.nut.2016.04.003 Aubrey, 2014, Measurement of skeletal muscle radiation attenuation and basis of its biological variation, Acta Physiol (Oxf), 210, 489, 10.1111/apha.12224 Fukushima, 2017, Impact of sarcopenia in the management of urological cancer patients, Expert Rev Anticancer Ther, 17, 455, 10.1080/14737140.2017.1301209 Arends, 2017, ESPEN guidelines on nutrition in cancer patients, Clin Nutr, 36, 11, 10.1016/j.clnu.2016.07.015 Peisch, 2017, Prostate cancer progression and mortality: a review of diet and lifestyle factors, World J Urol, 35, 867, 10.1007/s00345-016-1914-3